Skip to main content

Peer Review reports

From: Similar immunogenicity profiles between the proposed biosimilar MYL-1501D and reference insulin glargine in patients with diabetes mellitus: the phase 3 INSTRIDE 1 and INSTRIDE 2 studies

Original Submission
26 Feb 2021 Submitted Original manuscript
22 Mar 2021 Reviewed Reviewer Report
23 Mar 2021 Reviewed Reviewer Report - Yukihiro Fujita
18 May 2021 Author responded Author comments - Bin Sun
25 May 2021 Author responded Author comments - Bin Sun
Resubmission - Version 2
18 May 2021 Submitted Manuscript version 2
27 May 2021 Reviewed Reviewer Report - Yukihiro Fujita
2 Jun 2021 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
4 Jun 2021 Editorially accepted
26 Jun 2021 Article published 10.1186/s12902-021-00797-4

You can find further information about peer review here.

Back to article page